News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ADHD Medicine's Long-Term Safety Still A Question, Mario Negri Institute For Pharmacological Research Study


5/5/2014 7:04:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Scant research has been done on the long-term safety of drugs for attention-deficit/hyperactivity disorder (ADHD), a new analysis shows, though millions of American children have been taking them for decades. The U.S. Centers for Disease Control and Prevention estimates that 11 percent of American children between the ages of four and 17 - or 6.4 million - had been diagnosed with ADHD as of 2011. About half were taking drugs to treat the disorder.

Hey, check out all the research scientist jobs. Post your resume today!


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES